A new treatment strategy for acute liver failure

World Journal of Hepatology

Volumn 2, Issue 11, 2010, Pages 395-400

  Kotoh, Kazuhiro ^a   Kato, Masaki ^a   Kohjima, Motoyuki ^b   Nakamuta, Makoto ^b   Enjoji, Munechika ^c  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Acute liver failure; Ferritin; Hepatitis; Macrophages; Steroids

Indexed keywords

EID: 83155190052     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v2.i11.395     Document Type: Editorial

References (37)

1. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology 2008; 47: 1401-1415
2. Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009; 6: 542-553
3. Grodzicki M, Kotulski M, Leonowicz D, Zieniewicz K, Krawczyk M. Results of treatment of acute liver failure patients with use of the prometheus FPSA system. Transplant Proc 2009; 41: 3079-3081
4. Marudanayagam R, Shanmugam V, Gunson B, Mirza DF, Mayer D, Buckels J, Bramhall SR. Aetiology and outcome of acute liver failure. HPB (Oxford) 2009; 11: 429-434
5. Hiramatsu A, Takahashi S, Aikata H, Azakami T, Katamura Y, Kawaoka T, Uka K, Yamashina K, Takaki S, Kodama H, Jeong SC, Imamura M, Kawakami Y, Chayama K. Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single center. J Gastroenterol Hepatol 2008; 23: 1216-1222
6. Canbay A, Jochum C, Bechmann LP, Festag S, Gieseler RK, Yüksel Z, Lütkes P, Saner FH, Paul A, Gerken G. Acute liver failure in a metropolitan area in Germany: A retrospective study (2002 - 2008). Z Gastroenterol 2009; 47: 807-813
7. Akdogan M, Camci C, Gurakar A, Gilcher R, Alamian S, Wright H, Nour B, Sebastian A. The effect of total plasma exchange on fulminant hepatic failure. J Clin Apher 2006; 21: 96-99
8. Davenport A, Will EJ, Davison AM. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl 1993; 41: S245-S251
9. Sato S, Suzuki K, Takikawa Y, Endo R, Omata M. Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: An analysis of 1309 cases in a 15-year national survey. Hepatol Res 2004; 30: 155-161
10. Sekido H, Matsuo K, Takeda K, Ueda M, Morioka D, Kubota T, Tanaka K, Endo I, Togo S, Shimada H. Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplant Proc 2004; 36: 2355-2356
11. Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008; 49: 845-861
12. Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009; 43: 342-349
13. Fontana RJ. Acute liver failure due to drugs. Semin Liver Dis 2008; 28: 175-187
14. Matsui A, Mochida S, Ohno A, Nagoshi S, Hirose T, Fujiwara K. Plasma osteopontin levels in patients with fulminant hepatitis. Hepatol Res 2004; 29: 202-206
15. Hiraoka A, Horiike N, Akbar SM, Michitaka K, Matsuyama T, Onji M. Soluble CD163 in patients with liver diseases: Very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol 2005; 40: 52-56
16. Møller HJ, Gronbaek H, Schiodt FV, Holland-Fischer P, Schilsky M, Munoz S, Hassanein T, Lee WM. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol 2007; 47: 671-676
17. Kotoh K, Ueda A, Tanaka M, Miyazaki M, Kato M, Kohjima M, Enjoji M, Nakamuta M, Takayanagi R. A high prevalence of extreme hyperferritinemia in acute hepatitis patients. Hepatic Medicine: Evidence and Research 2009; 1: 1-7
18. Janka GE. Hemophagocytic syndromes. Blood Rev 2007; 21: 245-253
19. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002; 14: 548-552
20. Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008; 50: 1227-1235
21. Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology 1975; 68: 525-533
22. Eastham EJ, Bell JI, Douglas AP. Serum ferritin levels in acute hepatocellular damage from paracetamol overdosage. Br Med J 1976; 1: 750-751
23. Hengeveld P, Zuyderhoudt FM. Iron mobilisation with chelating agents during acute viral hepatitis. Hepatogastroenterology 1982; 29: 191-194
24. Hengeveld P, Zuyderhoudt FM, Jöbsis AC, van Gool J. Some aspects of iron metabolism during acute viral hepatitis. Hepatogastroenterology 1982; 29: 138-141
25. Milman N, Graudal N. Serum ferritin in acute viral hepatitis. Scand J Gastroenterol 1984; 19: 38-40
26. Triadou P, Regnat-Lusinchi A, Girot R. Use of the ferritin/alanine aspartate transaminase ratio as an iron overload marker independent of liver cell damage. Eur J Haematol 1989; 43: 423-427
27. Rees BB, Bowman JA, Schulte PM. Structure and sequence conservation of a putative hypoxia response element in the lactate dehydrogenase-B gene of Fundulus. Biol Bull 2001; 200: 247-251
28. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL. Lactate dehydrogenase 5 expression in operable colorectal cancer: Strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group. J Clin Oncol 2006; 24: 4301-4308
29. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. Oxygenregulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: Similarities with the erythropoietin 3' enhancer. Proc Natl Acad Sci USA 1994; 91: 6496-6500
30. Arai M, Mochida S, Ohno A, Ogata I, Fujiwara K. Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis. Gastroenterology 1993; 104: 1466-1471
31. Kotoh K, Enjoji M, Nakamuta M, Yoshimoto T, Kohjima M, Morizono S, Yamashita S, Horikawa Y, Yoshimitsu K, Tajima T, Asayama Y, Ishigami K, Hirakawa M. Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure. World J Gastroenterol 2006; 12: 6678-6682
32. Kotoh K, Enjoji M, Kato M, Kohjima M, Nakamuta M, Takayanagi R. A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: A retrospective study. Comp Hepatol 2008; 7: 6
33. Gregory B, Larson AM, Reisch J, Lee WM. Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure. J Investig Med 2010; 58: 707-710
34. Peláez-Luna M, Martinez-Salgado J, Olivera-Martinez MA. Utility of the MAYO End-Stage Liver Disease score, King' s College Criteria, and a new in-hospital mortality score in the prognosis of in-hospital mortality in acute liver failure. Transplant Proc 2006; 38: 927-929
35. Schiødt FV, Chung RT, Schilsky ML, Hay JE, Christensen E, Lee WM. Outcome of acute liver failure in the elderly. Liver Transpl 2009; 15: 1481-1487
36. Perkins JD. Another formula to determine the prognosis of patients with acute liver failure. Liver Transpl 2009; 15: 986-991
37. McKenzie TJ, Lillegard JB, Nyberg SL. Artificial and bioartificial liver support. Semin Liver Dis 2008; 28: 210-217